Enfoque para su manejo en atención primaria | 27 FEB 24

Cirrosis hepática

El manejo de atención primaria de la cirrosis y sus complicaciones
Autor/a: Asim Kichloo, Michael Aljadah, Michael Albosta, Zain El -Amir, Ghazaleh Goldar, y otros Cleveland Clinic Journal of Medicine. Volume 90 Number 11 November 2023.
INDICE:  1. Texto principal | 2. Referencias bibliográficas
Referencias bibliográficas

1. Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet 2014; 383(9930):1749–1761. doi:10.1016/S0140-6736(14)60121-5

2. Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratifi cation, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases [published correction appears in Hepatology 2017; 66(1):304]. Hepatology 2017; 65(1):310–335. doi:10.1002/hep.28906

3. Scaglione S, Kliethermes S, Cao G, et al. The epidemiology of cirrhosis in the United States: a population-based study. J Clin Gastroenterol 2015; 49(8):690–696. doi:10.1097/MCG.0000000000000208

4. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371(9615):838– 851. doi:10.1016/S0140-6736(08)60383-9

5. Smith A, Baumgartner K, Bositis C. Cirrhosis: diagnosis and management. Am Fam Physician 2019; 100(12):759–770.

6. Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol 2017; 112(1):18–35. doi:10.1038/ajg.2016.517

7. Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 2000; 46(12):2050–2068. doi:10.1093/clinchem/46.12.2050

8. Geng XX, Huang RG, Lin JM, Jiang N, Yang XX. Transient elastography in clinical detection of liver cirrhosis: a systematic review and meta-analysis. Saudi J Gastroenterol 2016; 22(4):294–303. doi:10.4103/1319-3767.187603

9. National Institute for Health and Care Excellence (NICE). Cirrhosis in over 16s: assessment and management. https://www.nice.org.uk/ guidance/ng50. Accessed September 25, 2023.

10. Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg 1964; 1:1–85. pmid:4950264

11. Tsoris A, Marlar CA. Use of the Child Pugh score in liver disease. 2023 Mar 13. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2023. pmid:31194448

12. Peng Y, Qi X, Guo X. Child-Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Medicine (Baltimore) 2016; 95(8):e2877. doi:10.1097/MD.0000000000002877

13. Merli M, Nicolini G, Angeloni S, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol 2003; 38(3):266–272. doi:10.1016/s0168-8278(02)00420-8

14. Ilyas JA, Kanwal F. Primary prophylaxis of variceal bleeding. Gastroenterol Clin North Am 2014; 43(4):783–794. doi:10.1016/j.gtc.2014.08.008

15. de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C; Baveno VII Faculty. Baveno VII–Renewing consensus in portal hypertension [published correction appears in J Hepatol 2022 Apr 14]. J Hepatol 2022; 76(4):959–974. doi:10.1016/j.jhep.2021.12.022

16. Kudo M, Zheng RQ, Kim SR, et al. Diagnostic accuracy of Imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study. Intervirology 2008; 51(suppl 1):-17–26. doi:10.1159/000122595

17. Heidelbaugh JJ, Sherbondy M. Cirrhosis and chronic liver failure: part II. Complications and treatment. Am Fam Physician 2006; 74(5):767–776. pmid:16970020

18. Suraweera D, Sundaram V, Saab S. Evaluation and management of hepatic encephalopathy: current status and future directions. Gut Liver 2016; 10(4):509–519. doi:10.5009/gnl15419

19. Shetty A, Jun Yum J, Saab S. The gastroenterologist’s guide to preventive management of compensated cirrhosis. Gastroenterol Hepatol (NY) 2019; 15(8):423–430. pmid:31592079

20. European Association for the Study of the Liver; European Organization for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma [published correction appears in J Hepatol 2012; 56(6):1430]. J Hepatol 2012; 56(4):908–943. doi:10.1016/j.jhep.2011.12.001

21. Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2018; 68(2):723–750. doi:10.1002/hep.29913



Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024